

Available online at doc.guandang.net
AdoptiveTcelltherapyofcancer
MalcolmKBrennerandHelenEHeslop
AdoptivetransferofTcellsspeci cforantigensexpressedontumorcellsisanattractivestrategyforproducingtargetedandlong-livedanti-tumoractivity.TcelltherapieshaveshownactivityinselectedclinicalapplicationsbutbroaderapplicationislimitedbyinadequatepersistenceoftransferredTcellsandbytumor-evasionstrategies.Currentresearchfocusesonde ningtheoptimumtypeofcellfortransfer,geneticallymodifyinginfusedTcellstoaugmentfunctionandovercometumorevasionstrategiesandmodulatingthehostenvironment.
Address
CenterforCellandGeneTherapy,BaylorCollegeofMedicine,TheMethodistHospitalandTexasChildren’sHospital,Houston,TX,UnitedStates
Correspondingauthor:Heslop,HelenE(hheslop@bcm.edu)
nasopharyngealcancer[9–12],providinginsightsintorequirementsforeffectiveimmunotherapy.
Tcellimmunotherapyforcancernonethelessfacessig-ni cantobstacles.Forexample,potentiallyimmunogenictumorshaveevolvedarangeofpassiveandactiveimmuneevasionstrategiestoavoidtheconsequencesofimmuneactivation[13,14],andtheimmuneresponsecanevenpromotetumorgrowth[15].Passiveevasiontacticsincludethefailuretopresenttumorantigensappropriatelytotheimmunesystemandpersistenttol-erancetotheself-antigenspresentontumorcells.Itisincreasinglyevidentthatanimmuneresponsemayalsoselecttumorvariantsthathavelostthetargetedantigens.Forexample,in5/17patientswhorelapsedwithAMLafterhaploidenticalHSCT,theregionofthehostChromosome6encodingthemismatchedHLAhaplo-typewasdeleted,withconsequentlossofthemajortargetfortheanti-tumoreffectofthedonorTcells[16 ].ActivesubversionofimmunitymayincludethepresenceoffactorssuchasTGFbinthetumormicroenvironmentthatdiminishTcellsurvivalandfunction,orthesecretionofchemokinesthatattractregulatoryorinhibitoryTcellsratherthanantitumorTeffectorcells.Recentlaboratoryinsightshaveelucidatedthemolecularbasisofmanyoftheseevasionstrategies,allowingthedevelopmentofpotentiallyeffectivecountermeasures[13].
CurrentOpinioninImmunology2010,22:251–257ThisreviewcomesfromathemedissueonTumourImmunology
EditedbyFredaStevensonandAnnaKarolinaPaluckaAvailableonline17thFebruary20100952-7915/$–seefrontmatter
#2010ElsevierLtd.Allrightsreserved.DOI10.1016/j.coi.2010.01.020
Introduction
Harnessingthecytotoxicpowerandtargetingabilityofthecellularimmunesystemcouldsigni cantlyadvancecancertherapy.Whilemonoclonalantibodytherapiesarenowwellestablishedinclinicalpractice[1],exploitationofthecellularimmuneresponsetocancerhasbeenslower,largelybecauseofitsgreatercomplexity.Ofthemultipleformsofcellularimmunotherapy[2,3],adop-tivetransferofTlymphocyteshasperhapsbeenthemostsuccessful.Forexample,unmanipulateddonorlympho-cyteinfusions(DLI)havebeenwidelyusedtotreatpatientswithrelapsedhematologicmalignanciesafterallogeneichemopoieticstemcelltransplantation(HSCT)[4],whileantitumorresponsespostHSCTcorrelatewithdevelopmentofadiverseTcellresponsespeci cforminorhistocompatibility[5]ortumor-associatedantigenssuchasWT1[6].Moreover,exvivoexpandeddonor-derivedcytotoxicspeci cTlymphocytes(CTLs)haveprovedhighlyeffectiveinpreventingortreatingviralinfectionsandEpstein-Barrvirus(EBV)lymphomasdevelopingpost-transplant[7 ,8].Intheautologousset-tingclinicalresponseshavebeenobservedfollowingTcelltherapiesinpatientswithmelanoma,lymphomaand
doc.guandang.net
Whatistheoptimalcelltotransfer?
Onelimitationofimmunotherapyhasbeenthesubopti-malpersistenceoftheadoptivelytransferredcells.Duringthepastyear,theoptimaltypeofTcellfortransfertoensureoptimalpersistenceandfunctionhasbeenextensivelystudied.InaprimatemodelofCMVinfectionBergeretal.reportedthatonlyantigen-speci cCD8clonesderivedfromcentralmemoryTcellsper-sistedlong-terminvivoandaccessedmemoryTcellniches[17 ].InamurinemodelusingtransgenicorretrovirallytransducedTcellsengineeredtoexpressatumor-speci cTcellreceptor,however,superioranti-tumoractivitywasseenineffectorcellsderivedfromnaiveTcells[18 ].OtherstudiesshowedthatinductionofWnt-beta-cateninexpressionpromotedgenerationofmemory‘stem’cellswithenhancedproliferativeandantitumorcapacitiesthatweremoreeffectiveforadop-tivetransferthanotherTcellsubsets[19 ].Thesedifferentconclusionsabouttheoptimalsubsetprobablyre ectthemodelsusedandemphasizethatmultiplefactorsdeterminethebestphenotypeforadoptivetrans-ferintoacompleximmunenetwork.Forthemomentweshouldbewaryofplacingexcessivefaithinbroadassertions.
CurrentOpinioninImmunology2010,22:251–257
to bring together a number of linked reviews that collectively cover the three major issues that we see in the development of adoptive T cell therapy: ...
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript Adoptive T cell therapy of cancer Ton N.M. Schumacher and The Division of ...
Adoptive T-cell therapy for melanoma: Production steps and associated costs Laszlo Radvanyi MD Anderson Cancer Center October 17, 2008 Advantages of ...
(Cancer J 2010;16: 367–373) GENERATING T-CELL CLONES FOR T-CELL THERAPY The generation of T-cell clones for adoptive therapy must address at a ...
Adoptive T-cell therapy for malignant disorders Daniel J. Powell Jr and ...T lymphocytes has emerged as an important advance in cancer immunotherapy, ...
James Yang Surgery Branch, National Cancer Institute Bethesda, MD T-Cell-...T-cells could augment the efficacy of adoptive cellular therapy Melanoma TIL...
针对癌症的抗体治疗 Antibody therapy of cancer_基础医学_医药卫生_专业资料。Antibody therapy of cancer Major Points ? Mechanisms of tumor cell killing ? ...
cells using anti-tumor T-cell receptors (TCR) or chimeric antigen receptors is a promising approach for the adoptive cell therapy of patients with cancer...
Adoptive T-Cell Transfer... 暂无评价 58页 免费 Adoptive T-cell therapy ...Effective cancer immunotherapy is dependent on the presence of large numbers ...
Adoptive cell transfer immunotherapy (ACT) of T cells shows great promise ...As a therapy to treat cancer, for example, ACT relies on the natural ...
热门文档